MLPerf results show how new GPUs and system-level design are enabling faster, scalable inference for large language models ...

Google's AI lab just released its own version of DeepSeek, causing Micron to sell off last week.

“I get asked all the time what I think about training versus inference – I'm telling you all to stop talking about training versus inference.” So declared OpenAI VP Peter Hoeschele at Oracle’s AI ...

Artificial intelligence startup Runware Ltd. wants to make high-performance inference accessible to every company and application developer after raising $50 million in Series A funding. It’s backed ...

Global IT spending has crossed the multitrillion-dollar mark, with AI infrastructure representing one of the fastest-growing ...

More investors need to hear of and learn about ASML.

Google has added two new service tiers to the Gemini API that enable enterprise developers to control the cost and ...

South Korean chipmaker Rebellions raised $400 million as it prepares to go public and compete against Nvidia in AI inference.

Highlights: Huawei launches Atlas 350, focused on AI inference, not training Claims up to 2.8× performance boost over ...

As regulators increasingly push large loads to “bring their own power,” LT350’s hybrid solar-plus-storage model provides predictable power cost, curtailment resilience, and reduced interconnection ...

SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform.

Artificial intelligence startup Runware Ltd. wants to make high-performance inference accessible to every company and application developer after raising $50 million in an early-stage funding round.